Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beta amyloid plaques are extracellular deposits primarily composed of aggregated amyloid beta (Aβ) protein. These structures are most commonly found in the grey matter of the brain and are a defining pathological feature of Alzheimer's disease. While some plaque formation can occur with normal aging, their abundance and association with neurofibrillary tangles distinguish Alzheimer’s pathology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta Amyloid Plaque.